Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Value of the AST/ALT Ratio Vs. APACHE II Score in Patients with Sepsis and Septic Shock

NCT06683794 is registered in ClinicalTrials.gov with Nermeen Gamil Ahmed as lead sponsor.

NCT NCT06683794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Value of the AST/ALT Ratio Vs. APACHE II Score in Patients with Sepsis and Septic Shock
Lead sponsor
Nermeen Gamil Ahmed
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2024
Completion date
December 1, 2025
Enrollment
142 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

e prognostic value of the ast/alt ratio vs. apache ii score in patients with sepsis and septic shock